September 13, 2007 - Millennium Research Group (MRG) conducted a detailed analysis of the stem cell therapy market in its "U.S. Markets for Stem Cell Therapies 2007" report, which shows while the market for stem cell therapies is in its infancy, it will grow rapidly as products are approved in the U.S.

September 12, 2007 - FlowCardia Inc., a medical device company developing a portfolio of endovascular devices for the treatment of coronary and peripheral chronic total occlusions (CTOs), announced the completion of enrollment into the PATRIOT study (Peripheral Approach To Recanalization In Occluded Totals), which is designed to assess the safety and efficacy of the peripheral line of CROSSER Catheters in lower limb CTOs.

September 12, 2007 - Cardica Inc. received the European CE Mark (Conformite Europeenne) for the C-Port Flex A Anastomosis System, a device that facilitates the automated anastomosis during less invasive coronary artery bypass graft (CABG) procedures.

September 11, 2007 - Terumo Interventional Systems announces the launch of Runthrough NS Coronary Guidewire in the U.S. market for use in percutaneous transluminal coronary angioplasties (PTCA), as the company expands its position in the coronary market.

Runthrough NS is designed to provide tip durability, complete torque transfer and enhanced steerability. This coronary guidewire boasts efficiency and reliability.

Cardica Inc. received the European CE Mark (Conformite Europeenne) for the C-Port Flex A Anastomosis System, a device that facilitates the automated anastomosis during less invasive coronary artery bypass graft (CABG) procedures.


When it comes to diagnosing disease, image is everything. It is difficult to treat what you can’t see. That’s especially true in the cardiac cath lab where cardiologists performing procedures ranging from simple diagnostic tests to more complex interventional maneuvers rely on imaging technology to guide their course.

New York’s Mount Sinai Heart has it all: a star-studded line-up of internationally renowned physicians, scientists and educators, cutting-edge research and unparalleled clinical services. Their secret to success — an integrated approach to cardiovascular healthcare that makes it all possible.


Since the introduction of the 64 multi-slice CT scanner, studies have examined the utility of this technology for diagnosing coronary artery disease (CAD), and cardiologists are rapidly adopting this technology to perform CT Angiography (CTA) for detecting CAD.

CT scanners have evolved over the years and are showing to have applications in the emergent and non-emergent evaluation of underlying cardiovascular issues. The general acceptance for cardiovascular evaluation by CT is limited due to ongoing studies.

More than ever before, cardiologists are adopting CT as the new standard for cardiac care. In the last five years, CT’s popularity as a diagnostic tool has exploded. Its ability to produce slices as thin as 0.5 mm creates a platform for evaluating patients, detecting disease at early stages and designing treatment roadmaps.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now